Lu Wei, Chen Song, Lai Chunhui, Lai Mingyue, Fang Hua, Dao Hong, Kang Jun, Fan Jianhua, Guo Weizhong, Fu Linchun, Andrieu Jean-Marie
Institut de Recherche sur les Vaccins et l'Immunothérapie des Cancers et du Sida, Université de Paris Descartes, Paris, France; Sino-French Collaborative Laboratory, Tropical Medicine Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.
Sino-French Collaborative Laboratory, Tropical Medicine Institute, Guangzhou University of Chinese Medicine , Guangzhou , China.
Front Immunol. 2016 Apr 18;7:134. doi: 10.3389/fimmu.2016.00134. eCollection 2016.
We previously demonstrated in the Chinese macaque model that an oral vaccine made of inactivated SIV and Lactobacillus plantarum induced CD8(+) regulatory T-cells, which suppressed the activation of SIV(+)CD4(+) T-cells, prevented SIV replication, and protected macaques from SIV challenges. Here, we sought whether a similar population of CD8(+) T-regs would induce the suppression of HIV replication in elite controllers (ECs), a small population (3‰) of HIV-infected patients with undetectable HIV replication. For that purpose, we investigated the in vitro antiviral activity of fresh CD8(+) T-cells on HIV-infected CD4(+) T-cells taken from 10 ECs. The 10 ECs had a classical genomic profile: all of them carried the KIR3DL1 gene and 9 carried at least 1 allele of HLA-B:Bw4-80Ile (i.e., with an isoleucine residue at position 80). In the nine HLA-B:Bw4-80Ile-positive patients, we demonstrated a strong viral suppression by KIR3DL1-expressing CD8(+) T-cells that required cell-to-cell contact to switch off the activation signals in infected CD4(+) T-cells. KIR3DL1-expressing CD8(+) T-cells withdrawal and KIR3DL1 neutralization by a specific anti-killer cell immunoglobulin-like receptor (KIR) antibody inhibited the suppression of viral replication. Our findings provide the first evidence for an instrumental role of KIR-expressing CD8(+) regulatory T-cells in the natural control of HIV-1 infection.
我们之前在中国猕猴模型中证明,由灭活的猴免疫缺陷病毒(SIV)和植物乳杆菌制成的口服疫苗可诱导CD8(+)调节性T细胞,这些细胞可抑制SIV(+)CD4(+)T细胞的激活,阻止SIV复制,并保护猕猴免受SIV攻击。在此,我们探究在精英控制者(ECs)中,是否有类似的CD8(+)调节性T细胞群体可诱导对HIV复制的抑制,精英控制者是一小部分(3‰)HIV感染患者,其体内HIV复制检测不到。为此,我们研究了新鲜CD8(+)T细胞对取自10名精英控制者的HIV感染的CD4(+)T细胞的体外抗病毒活性。这10名精英控制者具有典型的基因组特征:他们都携带KIR3DL1基因,9人携带至少1个HLA-B:Bw4-80Ile等位基因(即第80位带有异亮氨酸残基)。在9名HLA-B:Bw4-80Ile阳性患者中,我们证明表达KIR3DL1的CD8(+)T细胞具有强大的病毒抑制作用,这需要细胞间接触来关闭受感染CD4(+)T细胞中的激活信号。表达KIR3DL1的CD8(+)T细胞撤离以及用特异性抗杀伤细胞免疫球蛋白样受体(KIR)抗体进行KIR3DL1中和可抑制病毒复制的抑制作用。我们的研究结果首次证明了表达KIR的CD8(+)调节性T细胞在HIV-1感染自然控制中的重要作用。